Prescription medication sharing

American Journal of Public Health

Volumn 98, Issue 11, 2008, Pages 1926-1927

  Mitchell, Allen A ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID PLUS BUTALBITAL PLUS CAFFEINE; BENDECTIN; CHLOROTHIAZIDE; CLOMIFENE CITRATE; DEXTROPROPOXYPHENE; DIAZEPAM; HYDROCHLOROTHIAZIDE; PROCHLORPERAZINE MALEATE; SECOBARBITAL;

BIRTH DEFECT; CONGENITAL MALFORMATION; DRUG SAFETY; FETUS OUTCOME; HUMAN; LETTER; PHARMACOEPIDEMIOLOGY; PREGNANT WOMAN; PRENATAL EXPOSURE; PRESCRIPTION; CANADA; COOPERATION; FEMALE; HIGH RISK BEHAVIOR; INFORMATION PROCESSING; NOTE; PREGNANCY; STATISTICS; UNITED STATES;

ABNORMALITIES, DRUG-INDUCED; COOPERATIVE BEHAVIOR; DATA COLLECTION; FEMALE; HUMANS; ONTARIO; PREGNANCY; PRESCRIPTIONS, DRUG; RISK-TAKING; UNITED STATES;

EID: 55249107583     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2008.144261     Document Type: Letter

References (3)

1. Goldsworthy RC, Schwartz NC, Mayhorn CB. Beyond abuse and exposure: framing the impact of prescription-medication sharing. Am J Public Health. 2008; 98:1115-1121.
2. Mitchell AA, Rosenberg L, Shapiro S, et al. Birth defects related to Bendectin use in pregnancy. I. Oral clefts and cardiac defects. JAMA. 1981;245:2311-2314.
3. Mitchell AA, Cottler LB, Shapiro S. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol. 1986;123:670-676.